These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2869019)

  • 1. Aridicins, novel glycopeptide antibiotics. III. Preparation, characterization, and biological activities of aglycone derivatives.
    Sitrin RD; Chan GW; Chapin F; Giovenella AJ; Grappel SF; Jeffs PW; Phillips L; Snader KM; Nisbet LJ
    J Antibiot (Tokyo); 1986 Jan; 39(1):68-75. PubMed ID: 2869019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A40926 aglycone and pseudoaglycones: preparation and biological activity.
    Selva E; Goldstein BP; Ferrari P; Pallanza R; Riva E; Berti M; Borghi A; Beretta G; Scotti R; Romanò G
    J Antibiot (Tokyo); 1988 Sep; 41(9):1243-52. PubMed ID: 3053550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.
    Metzler CM; DeHaan RM
    J Infect Dis; 1974 Dec; 130(6):588-94. PubMed ID: 4372272
    [No Abstract]   [Full Text] [Related]  

  • 5. Aridicins, novel glycopeptide antibiotics. I. Taxonomy, production and biological activity.
    Shearer MC; Actor P; Bowie BA; Grappel SF; Nash CH; Newman DJ; Oh YK; Pan CH; Nisbet LJ
    J Antibiot (Tokyo); 1985 May; 38(5):555-60. PubMed ID: 4019307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aridicins, novel glycopeptide antibiotics. II. Isolation and characterization.
    Sitrin RD; Chan GW; Dingerdissen JJ; Holl W; Hoover JR; Valenta JR; Webb L; Snader KM
    J Antibiot (Tokyo); 1985 May; 38(5):561-71. PubMed ID: 4019308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kibdelins, novel glycopeptide antibiotics. I. Discovery, production, and biological evaluation.
    Shearer MC; Giovenella AJ; Grappel SF; Hedde RD; Mehta RJ; Oh YK; Pan CH; Pitkin DH; Nisbet LJ
    J Antibiot (Tokyo); 1986 Oct; 39(10):1386-94. PubMed ID: 3781909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.
    Chow AW; Patten V; Guze LB
    J Infect Dis; 1975 Feb; 131(2):182-5. PubMed ID: 163867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloropolysporins A, B and C, novel glycopeptide antibiotics from Faenia interjecta sp. nov. V. Comparative studies of the biological properties.
    Takatsu T; Katayama T; Nakajima M; Takahashi S; Haneishi T; Magaribuchi T; Tajima M
    J Antibiot (Tokyo); 1987 Jul; 40(7):946-52. PubMed ID: 3624073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of anaerobes to 8 antibiotics].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):645-7. PubMed ID: 3534760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptide antibiotics: from conventional molecules to new derivatives.
    Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
    Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
    Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
    Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of fluorescent glycopeptide derivatives by two consecutive high pressure liquid chromatographic procedures.
    Joos B; Lüthy R
    J Antibiot (Tokyo); 1988 Mar; 41(3):302-7. PubMed ID: 2966790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of anaerobic bacteria to meropenem.
    Nord CE; Lindmark A; Persson I
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():113-7. PubMed ID: 2553656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of selected antibiotics against anaerobes.
    Wexler HM; Finegold SM
    Clin Ther; 1987; 10 Suppl A():12-8. PubMed ID: 3690606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activities of lincomycin and clindamycin against anerobic bacteria].
    Ninomiya K; Watanabe K; Ueno K; Suzuki S; Mou I
    Jpn J Antibiot; 1973 Apr; 26(2):157-62. PubMed ID: 4354698
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and mode of action of hydrophobic derivatives of the glycopeptide antibiotic eremomycin and des-(N-methyl-D-leucyl)eremomycin against glycopeptide-sensitive and -resistant bacteria.
    Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Isakova EB; Reznikova MI; Goldman RC; Branstrom AA; Baizman ER; Longley CB; Sztaricskai F; Batta G; Preobrazhenskaya MN
    J Med Chem; 2002 Mar; 45(6):1340-7. PubMed ID: 11882003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The structure and antimicrobial activity of the partial degradation products of the antibiotic eremomycin].
    Berdnikova TF; Lomakina NN; Olsuf'eva EN; Aleksandrova LG; Potapova NP; Rozynov BV; Malkova IV; Orlova GI
    Antibiot Khimioter; 1991 Jun; 36(6):28-31. PubMed ID: 1910324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.